Evidence that transforming growth factor-β is a hormonally regulated negative growth factor in human breast cancer cells

Cornelius Knabbe, Marc E. Lippman, Lalage M. Wakefield, Kathleen C. Flanders, Attan Kasid, Rik Derynck, Robert B. Dickson

Research output: Contribution to journalArticle

821 Scopus citations

Abstract

The hormone-dependent human breast cancer cell line MCF-7 secretes transforming growth factor-β (TGF-β), which can be detected in the culture medium in a biologically active form. These polypeptides compete with human platelet-derived TGF-β for binding to its receptor, are biologically active in TGF-β-specific growth assays, and are recognized and inactivated by TGF-β-specific antibodies. Secretion of active TGF-β is induced 8 to 27-fold under treatment of MCF-7 cells with growth inhibitory concentrations of antiestrogens. Antiestrogen-induced TGF-β from MCF-7 cells inhibits the growth of an estrogen receptor-negative human breast cancer cell line in coculture experiments; growth inhibition is reversed with anti-TGF-β antibodies. We conclude that in MCF-7 cells, TGF-β is a hormonally regulated growth inhibitor with possible autocrine and paracrine functions in breast cancer cells.

Original languageEnglish (US)
Pages (from-to)417-428
Number of pages12
JournalCell
Volume48
Issue number3
DOIs
StatePublished - Feb 13 1987

ASJC Scopus subject areas

  • Biochemistry, Genetics and Molecular Biology(all)

Fingerprint Dive into the research topics of 'Evidence that transforming growth factor-β is a hormonally regulated negative growth factor in human breast cancer cells'. Together they form a unique fingerprint.

Cite this